Future Fields delivered a production campaign with 100% On-Time, In-Full (OTIF) delivery, reflecting exceptional order accuracy and reliability for the mission-critical protein.
Client Profile:
- Industry: Life Sciences
- Need: High volume of mission-critical recombinant proteins
- Result: Achieved sequence to scale in 7 months, reducing cost and supply chain risk for the client
THE CHALLENGE
A Client relied on the consistent, large-scale procurement of a mission-critical recombinant protein that was required for diverse, complex end applications. Facing escalating operational costs, the Client sought to address the prevailing high market price of this essential protein. The primary need was to implement a more cost-effective and flexible supply chain solution that could readily accommodate fluctuating volumes based on demand within a specific timeline.
The current industry standard for producing large-scale recombinant proteins relies on mammalian cell lines. Achieving this requires stable cell line development (CLD) with optimal protein expression and growth characteristics. This process, however, presents numerous inherent limitations:
- Significant increase in the production timeline
- No certainty of a stable line and a high risk of epigenetic drift
- Increased costs to meet fluctuating volume demand
In the full case study, you will find Future Fields’ strategy and tailored approach to achieve the following for the Client:
Significant reduction in the cost
Guaranteed generation of stable production strains
Flexible and reliable supply capable of rapid, on-demand scaling
Consistent and predictable source of the protein